Polymer-based siRNA delivery: Perspectives on the fundamental and phenomenological distinctions from polymer-based DNA delivery

被引:435
作者
Gary, Dana J.
Puri, Nitin
Won, You-Yeon [1 ]
机构
[1] Purdue Univ, Sch Chem Engn, W Lafayette, IN 47907 USA
[2] Ambion Inc, Austin, TX 78744 USA
关键词
RNA interference (RNAi); siRNA delivery; DNA delivery; Polymer; Polycation-based gene delivery;
D O I
10.1016/j.jconrel.2007.05.021
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Gene therapy holds tremendous promise in the treatment of many genetic and acquired diseases. The future of gene therapy in humans, however, is contingent upon the discovery of safe and effective carriers of genetic material. Polymers represent a class of materials that can be extensively modified to meet the needs of a particular gene delivery system. A variety of polymer formulations have been proposed in the literature as potential carriers, most of which facilitate gene delivery by encapsulating, and in some cases, condensing nucleic acids into nano-sized particles which can then be taken up by cells. Crucial to successful delivery of the gene to a cell is the polymer's ability to protect its contents from degradation in the extracellular environment. A well-designed carrier will also promote cellular uptake and intracellular release of the nucleic acid. In the past, a common approach to gene therapy has been to transfect cells with a polymer-encapsulated DNA plasmid designed to replace a defective gene in the target-cell genome. Within the last few years, however, RNA interference (RNAi) has emerged as a novel therapeutic pathway by which harmful genes can be "silenced" by delivering complementary short interfering RNA (siRNA) to target cells. siRNA delivery facilitated by polymers, although very promising, suffers from many of the same limitations as DNA delivery. This review will (1) highlight the similarities and differences between these two methods of gene therapy and (2) discuss how some of the remaining challenges in siRNA delivery facilitated by polymers can be addressed by applying knowledge from the longer-studied problem of DNA delivery. (C) 2007 Elsevier B.V. All rights reserved.
引用
收藏
页码:64 / 73
页数:10
相关论文
共 93 条
[1]   A powerful nonviral vector for in vivo gene transfer into the adult mammalian brain: Polyethylenimine [J].
Abdallah, B ;
Hassan, A ;
Benoist, C ;
Goula, D ;
Behr, JP ;
Demeneix, BA .
HUMAN GENE THERAPY, 1996, 7 (16) :1947-1954
[2]   Synthesis of biodegradable multi-block copolymers of poly(L-lysine) and poly(ethylene glycol) as a non-viral gene carrier [J].
Ahn, CH ;
Chae, SY ;
Bae, YH ;
Kim, SW .
JOURNAL OF CONTROLLED RELEASE, 2004, 97 (03) :567-574
[3]   The ins and outs of RNAi in mammalian cells [J].
Banan, M ;
Puri, N .
CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2004, 5 (05) :441-450
[4]   Insights into the kinetics of siRNA-mediated gene silencing from live-cell and live-animal bioluminescent imaging [J].
Bartlett, DW ;
Davis, ME .
NUCLEIC ACIDS RESEARCH, 2006, 34 (01) :322-333
[5]   Antisense oligonucleotides: Is the glass half full or half empty? [J].
Bennett, CF .
BIOCHEMICAL PHARMACOLOGY, 1998, 55 (01) :9-19
[6]   Peptide-mediated RNA delivery: a novel approach for enhanced transfection of primary and post-mitotic cells [J].
Bettinger, T ;
Carlisle, RC ;
Read, ML ;
Ogris, M ;
Seymour, LW .
NUCLEIC ACIDS RESEARCH, 2001, 29 (18) :3882-3891
[7]   EVIDENCE THAT THE PATHWAY OF TRANSFERRIN RECEPTOR MESSENGER-RNA DEGRADATION INVOLVES AN ENDONUCLEOLYTIC CLEAVAGE WITHIN THE 3' UTR AND DOES NOT INVOLVE POLY(A) TAIL SHORTENING [J].
BINDER, R ;
HOROWITZ, JA ;
BASILION, JP ;
KOELLER, DM ;
KLAUSNER, RD ;
HARFORD, JB .
EMBO JOURNAL, 1994, 13 (08) :1969-1980
[8]  
Bishop NE, 1997, REV MED VIROL, V7, P199, DOI 10.1002/(SICI)1099-1654(199712)7:4<199::AID-RMV203>3.0.CO
[9]  
2-F
[10]   Purification of polyethylenimine polyplexes highlights the role of free polycations in gene transfer [J].
Boeckle, S ;
von Gersdorff, K ;
van der Piepen, S ;
Culmsee, C ;
Wagner, E ;
Ogris, M .
JOURNAL OF GENE MEDICINE, 2004, 6 (10) :1102-1111